MedWatch

Leo Pharma's climate targets receive science-based stamp of approval

The Science Based Targets initiative has approved Leo Pharma’s emission reduction targets to combat climate change.

Photo: MAGNUS MØLLER

Leo Pharma has announced in a press release that its emission reduction targets have been validated by the Science Based Targets initiative (SBTi), which is a collaboration between the World Resources Institute, UN Global Compact and the World Wide Fund (WWF) and more.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs